Refresh

Akums Drugs & Pharmaceuticals Ltd. - Research Center

544222 AKUMS Group (B) BSE data
Back to Company

Results

Statement

More

Cash Flow
(Rs crore)
Mar ' 23

Profit before tax

150.32

Net cashflow-operating activity

94.01

Net cash used in investing activity

-202.17

Netcash used in fin. activity

89.90

Net inc/dec in cash and equivlnt

-18.26

Cash and equivalnt begin of year

25.49

Cash and equivalnt end of year

7.23
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com